Back to RAPP
TRV GP V, LLC RAPP Position History
Rapport Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$211M
Q3 2026
Peak value
$261.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $216.5M |
| Q1 2026 | $223.3M |
| Q2 2026 | $261.7M |
| Q3 2026 | $211M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $211M | 6.28M | — | — |
| Q2 2026 | $261.7M | 6.28M | — | — |
| Q1 2026 | $223.3M | 7.14M | — | — |
| Q4 2025 | $216.5M | 7.14M | — | — |
Other funds holding RAPP
$165.5M
$155.4M
$133.6M
$133.4M
$130.3M
$125.3M
$125.2M
$122.7M